Blaine Davis
Patrimonio netto: 284 674 $ in data 30/06/2026
Patrimonio netto: 284 674 $ in data 30/06/2026
Mr. Blaine T.
Davis is a Chief Financial Officer at Cartesian Therapeutics, Inc. Mr. Davis was previously employed as a Chief Financial Officer by Selecta Biosciences, Inc., a Chief Financial Officer by Protara Therapeutics, Inc., a Vice President, Head-IR & Corporate Communications by Insmed, Inc., a President by Endo Ventures Unlimited Co., a SVP-Investor Relations & Corporate Communications by Endo International Ltd., a SVP-Corporate Affairs & Investor Relations Contact by Endo Health Solutions, Inc., a Director-Business Development by Bristol Myers Squibb Co., and a Vice President-Capital Markets by Thomcorp Holdings, Inc. He received his undergraduate degree from Middlebury College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0,09% | 14/04/2026 | 27.320 ( 0,09% ) | 284 674 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|
| Società | Posizione | Fine |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/01/2024 |
| PROTARA THERAPEUTICS, INC. | Direttore Finanziario/CFO | 15/07/2022 |
| INSMED INCORPORATED | Contatto Relazioni con gli Investitori | 01/01/2020 |
Endo Health Solutions, Inc.
Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures analgesics pharmaceutical products | Public Communications Contact | 01/12/2016 |
Endo Ventures Ltd.
Endo Ventures Ltd. Part of Endo International Plc, Endo Ventures Ltd. is an Irish specialty healthcare company. The company is based in Dublin, Ireland. Endo Ventures focuses on meeting the needs of today's healthcare customers by providing affordable, high-quality generic pharmaceuticals that offer new options for patients, providers, and payers. | Presidente | 01/01/2015 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Endo Health Solutions, Inc.
Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures analgesics pharmaceutical products | Health Technology |
Insmed, Inc.
Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Selecta Biosciences, Inc.
Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
Thomcorp Holdings, Inc.
Thomcorp Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Provides information, news, and technology solutions to the financial community | Commercial Services |
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endo Ventures Ltd.
Endo Ventures Ltd. Part of Endo International Plc, Endo Ventures Ltd. is an Irish specialty healthcare company. The company is based in Dublin, Ireland. Endo Ventures focuses on meeting the needs of today's healthcare customers by providing affordable, high-quality generic pharmaceuticals that offer new options for patients, providers, and payers. | |
Protara Therapeutics, Inc.
Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale